Laura Jacobson is head of the sleep and cognition group at the Florey Institute of Neuroscience and Mental Health in Melbourne, Australia. She obtained her PhD in neuropharmacology (Summa Cum Laude) in 2006 from the University of Basel in Switzerland. In 2007, Dr. Jacobson joined the Novartis Institutes for Biomedical Research (Basel), where she headed a preclinical pharmacology laboratory, conducting drug discovery research for neurodegenerative and sleep disorders. She then moved to Australia and established the sleep and cognition group at the Florey in 2016. Her research focuses on the neurobiology and pharmacology of sleep and arousal and their roles in decision making, cognitive and emotional processes in health and in neurodegenerative, proteinopathic disorders. Dr. Jacobson’s work is supported by the Alzheimer’s Association, Merck, Sharp & Dohme Investigator Studies Program, the National Health and Medical Research Council of Australia and the Michael J. Fox Foundation.
Using Sleep Modulation to Enhance the Brain’s Waste Clearance Mechanisms as an Approach to Limiting the Progression of Parkinson’s Disease